Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:1284-1289

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Farinaro, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Farinaro, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*LITHIUM COMPOUNDS
*LITHIUM, ELEMENTAL
*SODIUM
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1998;31:1284-1289.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Red Blood Cell Sodium-Lithium Countertransport and Risk of Future Hypertension

The Olivetti Prospective Heart Study

Pasquale Strazzullo; Alfonso Siani; Francesco P. Cappuccio; Maurizio Trevisan; Eliana Ragone; Luigina Russo; Roberto Iacone; ; Eduardo Farinaro

From the Department of Clinical and Experimental Medicine (P.S., E.R., L.R., R.I.) and Community Medicine–Department of Hygiene (E.F.), "Federico II" University of Naples Medical School, Naples; the Epidemiology and Prevention Unit, Institute of Food Sciences and Technology, National Research Council, Avellino (A.S.), Italy; the Blood Pressure Unit, Department of Medicine, St George's Hospital Medical School, London, UK (F.P.C.); and the Department of Social and Preventive Medicine, State University of New York at Buffalo (M.T.).

Correspondence to P. Strazzullo, MD, Department of Clinical and Experimental Medicine, "Federico II" University of Naples, via S. Pansini 5, 80131 Naples, Italy. E-mail strazzul{at}unina.it

Abstract—An elevated red blood cell (RBC) sodium-lithium countertransport (Na-Li CT) is associated with high blood pressure (BP) in cross-sectional investigations; however, its value as a predictor of future hypertension, and thus of cardiovascular risk, has not been defined. The present study evaluated the association between Na-Li CT and risk of future hypertension in a sample of 106 untreated normotensive middle-aged men participating in the Olivetti Prospective Heart Study in southern Italy. BP, anthropometric and metabolic variables, and RBC Na-Li CT were measured at baseline in 1987 and at a follow-up visit in 1994 through 1995. Na-Li CT was stable over time (r=0.85) and was significantly associated to systolic BP in both visits. Of the 106 initially normotensive participants, 14 were found to be hypertensive at the 8-year follow-up examination. Eleven of these 14 hypertensives were in the highest tertile of systolic BP at baseline, and 9 of 11 also had an elevated baseline Na-Li CT. In multiple logistic regression analysis, baseline BP, Na-Li CT, and age were all significant predictors of the risk of future hypertension. Individuals with baseline systolic BP in the highest tertile had a 60% risk of developing hypertension if their Na-Li CT was also high, whereas their risk was only 5% if Na-Li CT was in the two lowest tertiles (P=0.003). RBC Na-Li CT was a valuable predictor of subsequent hypertension in middle-aged men with a high-normal BP level for their age.


Key Words: hypertension, essential • blood pressure • risk factors • ion transport • genetics • erythrocytes




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
C. G. Savopoulos, A. I. Hatzitolios, N. A. Katsiki, M. Baltatzi, M. Kosmidou, N. Raikos, D. P. Mikhailidis, A. G. Ziakas, G. Kaiafa, and N. Tsesmeli
Sodium-Lithium Countertransport Activity in Healthy, Dyslipidemic, and Hypertensive Individuals
Angiology, January 1, 2009; 59(6): 727 - 735.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Xiang, M. Feng, S. Muend, and R. Rao
A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension
PNAS, November 20, 2007; 104(47): 18677 - 18681.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
O. Vaccaro, V. Cuomo, M. Trevisan, M. Cirillo, W. Panarelli, M. Laurenzi, M. Mancini, G. Riccardi, and On behalf of the Gubbio Study Research Group
Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes
Int. J. Epidemiol., October 1, 2005; 34(5): 1123 - 1128.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Glorioso, F. Filigheddu, D. Cusi, C. Troffa, M. Conti, M. Natalizio, G. Argiolas, C. Barlassina, and G. Bianchi
{alpha}-Adducin 460Trp Allele Is Associated With Erythrocyte Na Transport Rate in North Sardinian Primary Hypertensives
Hypertension, February 1, 2002; 39(2): 357 - 362.
[Abstract] [Full Text] [PDF]